Home » Agenda » Day 2

Day 2

Advancing Personalised Care Congress 2022 Americas

San Francisco, USA

5th - 6th December 2022

  • Auditorium 1

COLLECTIVE DATA AND DIGITAL HEALTH

  • How the focus on digital patient engagement helps healthcare providers create a greatly improved personalized patient experience from start to finish.
  • Imperative for engaging end-users in each phase of digital health design
  • Techniques to facilitate better digital health design and implementation.
  • Bridging the divide between technology companies, patients, and clinicians regarding effective development and use of digital health
  • The need to develop new, scalable and expandable big data infrastructure and analytical methods
  • The nature of big data and the role of semantic web and data analysis for generating “smart data”
  • How to create a system that makes big data robust and smart for healthcare providers and patients
  • Accessing unlimited online opportunity to learn more about diseases, seek and or give assistance.
  • Importance of finding and connecting with others infected or affected by the same illness or disease.
  • Opportunity to exchange relevant data on their condition, treatment , symptoms, side effects, etc.
  • Addressing the challenge of data protection to ‘go digital’
  • The fundamental rights to privacy and to the protection of personal data have become more important for the protection of human dignity than ever before.
  • Ethical dimension of data processing.
  • The need for a new regulatory framework, guaranteeing the rights of individuals.
  • Drivers and scale-up capabilities to advance RWD life cycle
  • Adopting the best practices and overcoming the associated challenges
  • Gauging the progress brought to downstream use by better data life cycle practices.
  • Dynamic data strategy agendas that overcome fragmentation and are representative of populations.
  • Acknowledging deterioration of public trust in the use and commercialization of healthcare data through transparency and engagement
  • Right governance in place for your critical data assets
  • Addressing patients on social media
  • Looking at issues around bluetooth hacking in medical devices
  • How does data security deal with the technical framework of keeping data secure and available?
  • How can we protect ourselves?

CHALLENGES & TRENDS IN THE DEVELOPMENT OF PERSONALISED MEDICINE

  • Benefit, risk evaluation and regulatory decision making
  • Emerging new clinical trials design
  • Use of data derived from several independent studies
  • HTAs acceptance
  • What are the life-changing potential of personalised medicine in improving health outcomes?What are the role of clinical research in facilitating personalised medicine development?
  • Best practices and lessons learned for timely access to the targeted population
  • Key factors influencing cost-effectiveness of personalised medicines
  • Value-based approach to inform policy decisions about reimbursement and investment in research
    and development
  • Societal perspective including opportunity costs, such as out-of-pocket patient costs, other indirect
    medical costs, also loss of income or productivity
  • Importance of individual and public engagements
  • New skills for healthcare professionals and novel tools for delivery
  • What must be done for the successful implementation of PM in all perspectives?
  • The use of health related data
  • How to develop sustainable economic models that allow improved therapy, diagnostic and preventive
    approaches as new healthcare concepts for the benefit of the public?
Scroll to Top